University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant

UMEM Educational Pearls

  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

601-620 of 884 results with category "Critical Care"

Previous  |  1 |  ... |  26 |  27 |  28 |  29 |  30 |  31 |  32 |  33 |  34 |  35 |  36 |  ... |  45 |  Next

Title: Crashing Cardiac Transplant Patient

Category: Critical Care

Posted: 1/8/2013 by Mike Winters, MBA, MD

The Crashing Cardiac Transplant Patient

  • Approximately 2000 patients receive a cardiac transplant each year in the United States.
  • With improvements in surgical techniques, immunosuppression, and management of complications, graft half-life is now approximately 13 years; thereby increasing the likelihood that a cardiac transplant patient will show up in your ED. 
  • In the crashing cardiac transplant patient, think of the following causes for acute decompensation:
    • Acute rejection
    • Primary graft failure
    • RV failure
    • Sepsis
  • For patients with primary graft failure initiate inotropic support with dobutamine, epinephrine, milrinone, or isoproteronol.  Those failing standard inotropes will likely require mechanical circulatory support (VAD) or ECMO.
  • Patients with acute RV failure will often require the combination of a pulmonary vasodilator (inhaled NO, prostaglandins) and inotropic agent. In addition, it is critical to avoid hypercapnia and hypoxia.  

Show References

Chacko P, Philip S. Emergency department presentation of heart transplant recipients with acute heart failure. Heart Failure Clinics 2009; 5:129-143.

Costanzo MR, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29:914.956.



Title: Is that rash is a mess? Maybe it s DRESS.

Category: Critical Care

Posted: 1/1/2013 by Haney Mallemat, MD

DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) or DIHS (Drug-Induced Hypersensitivity Syndrome) is a potentially life-threatening adverse drug-reaction.

Incidence is 1/1,000 to 1/10,00 drug exposures. It occurs 2-6 weeks after the drug is first introduced, distinguishing it from other adverse drug-reactions which typically occur sooner.

The syndrome classically includes:

  • Severe skin eruptions (typically morbilliform or erythrodermic eruptions)
  • Hematologic abnormalities (eosinophilia or atypical lymphocytosis)
  • Organ involvement; e.g., hepatic (most common), pneumonitis, renal failure, etc.
  • Fevers
  • Arthralgia
  • Lymphadenopathy

The most commonly implicated drugs are anticonvulsants (e.g., carbamazepine, phenobarbital, and phenytoin), sulfonamides, and allopurinol. 

Recovery is typically complete after discontinuing the offending drug; systemic steroids may promote resolution of the illness.

Show References

Cacoub P. et al. The DRESS syndrome: a literature review. Am J Med 2011 Jul;124(7):588-97. http://www.ncbi.nlm.nih.gov/pubmed/21592453

Follow me on Twitter (@criticalcarenow) or on Google+ (+criticalcarenow)

 


Title: VV-ECMO for Refractory Hypoxemia

Category: Critical Care

Posted: 12/25/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

VV-ECMO for Refractory Hypoxemia

  • In the absence of significant cardiac disease, patients with refractory hypoxic respiratory failure should be considered for venovenous extracorporeal membrane oxygenation (VV-ECMO).
  • Though indications vary slightly among organizations, the Extracorporeal Life Support Organization states that ECMO is indicated when the PaO2/FiO2 is < 80 mm Hg on FiO2 > 90% or safe plateau pressures (< 30 cm H2O) cannot be maintained.
  • A few pearls when initiating VV-ECMO:
    • Fluids are often needed in the first few hours after initiation of ECMO
    • Reduce tidal volumes to maintain plateau pressures < 25 cm H2O
    • Decrease FiO2 to maintain oxygen saturations > 88%
    • Use a hemoglobin threshold of 7-8 g/dL for blood transfusion

Show References

Combes A, et al. What is the niche for extracorporeal membrane oxygenation in severe acute respiratory distress syndrome? Curr Opin Crit Care 2012; 18:527-32.



Title: Do Monitors Matter?

Category: Critical Care

Posted: 12/18/2012 by Haney Mallemat, MD

Management of patients with severe traumatic brain injury (TBI) typically involves the use of invasive intra-parenchymal pressure monitors. Although use of these monitors is recommended by TBI management guidelines, good quality evidence of benefit is lacking.

A recently published study evaluated the outcomes of TBI patients using a management protocol incorporating either an intracranial pressure (ICP) monitor compared to use of the clinical exam PLUS serial neuroimaging; a total of 324 patients were prospectively randomized into either group.

The primary study outcome was a composite of survival, impaired consciousness, and functional status at both three and six months.

The results of the study did not show a significant difference in the:

  • Primary outcome  
  • Median length of ICU stay
  • Distribution of serious adverse events

Bottom line: This study suggests that clinical exam PLUS serial neuroimaging may perform as well as invasive intra-parenchymal monitors for guiding therapy in TBI patients.

Show References

Chestnut, R. et al.  A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury. NEJM 2012 Dec 12. http://www.ncbi.nlm.nih.gov/pubmed/23234472

Follow me on Twitter (@criticalcarenow) or Google+ (+haney mallemat)

 



Title: Ultrasound-Guided Pericardiocentesis

Category: Critical Care

Posted: 12/11/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

Ultrasound-Guided Pericardiocentesis

  • Though emergent pericardiocentesis is a relatively rare procedure in the ED, it is a critical intervention in patients with effusion and life-threatening instability/PEA arrest.
  • Ultrasound-guided pericardiocentesis is preferred over the traditional "blind" approach, as it allows the provider to choose an optimal position and is associated with fewer complications.
  • A few pearls when using ultrasound for emergent pericardiocentesis:
    • Consider placing an NGT for abdominal decompression.
    • Don't mistake the epicardial fat pad for an effusion; fat pads don't change size and usually move in concert with the ventricle.
    • The apical 4-chamber view tends to be the most common probe position, as the largest collection of fluid is usually around the apex.
    • If you are unsure about your needle location, inject 5-ml of agitated saline to confirm you are in the pericardial space.

Show References

L'Italien AJ. Critical cardiovascular skills and procedures in the emergency department. Emerg Med Clin N Am 2013; 31:151-206.

Tirado A, Wu T, Noble VE, et al. Ultrasound-guided procedures in the emergency department - Diagnostic and therapeutic asset. Emerg Med Clin N Am 2013; 31:117-149.



Title: Labs in Anaphylaxis

Category: Critical Care

Keywords: anaphylaxis, tryptase, diagnosis (PubMed Search)

Posted: 12/6/2012 by Ellen Lemkin, MD, PharmD (Updated: 9/4/2026)

  • Serum total tryptase measurements may be useful for confirmation of venom or drug induced anaphylaxis (not as useful for food induced)
  • Can send serial tryptase levels at the time of presentation, 1-2 hours later, and at resolution
  • This is NOT helpful for confirmation at the time of the episode, as it takes several hours to perform

Show References

Simons EF, Ardusso LE, Bilo MB, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis.



Title: Management of AKI

Category: Critical Care

Posted: 11/27/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

Managing Critically Ill Patients with AKI

  • Acute kidney injury (AKI) occurs in almost 50% of hospitalized patients and is an independent risk factor for mortality. 
  • Updated guidelines have recently been published on the management of patients with AKI.
  • Pearls for the management of patients with, or at risk of, AKI include:
    • Optimize volume status and perfusion pressure
      • Crystalloids preferred over colloids
      • Consider vasopressors to maintain MAP > 65 mm Hg
    • Avoid nephrotoxic drugs
    • Control co-factors
      • Monitor intra-abdominal pressure
      • Avoid hyperglycemia - target glucose < 150 mg/dL

Show References

Brienza N, et al. Protocoled resuscitation and the prevention of acute kidney injury. Curr Opin Crit Care 2012; 18:613-622.

Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2012; 2(S):1-138.



Title: How Low, Should You Go?

Category: Critical Care

Posted: 11/20/2012 by Haney Mallemat, MD

A low-tidal volume (or protective) strategy of mechanical ventilation (i.e., tidal volume of 6-8cc/kg of ideal body weight) has previously been demonstrated to be beneficial in patients with acute respiratory distress syndrome (ARDS).

A meta-analysis was recently performed to determine whether this strategy of mechanical ventilation is also beneficial for patients without lung injury prior to initiation of mechanical ventilation.

Dr. Neto, et al. performed a meta-analysis of 20 studies (total of 2,822 mechanically ventilated patients) comparing a conventional ventilation strategy (average tidal volume was 10.6 cc/kg) to a protective ventilation strategy (average tidal volume was 6.4 cc/kg) of mechanical ventilation.

The authors concluded that patients ventilated with a protective lung-strategy had reductions in:

  • Mortality
  • Lung injury and ARDS
  • Atelectasis
  • Pulmonary infections          
  • Length of hospital stay

Bottom-line: This meta-analysis supports the notion that a strategy of low-tidal volume ventilation may have benefits for patients without ARDS, however prospective studies are needed.

Show References

Neto, S. et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome. JAMA, Oct. 24/31; 308;16.

Follow me on Twitter (@criticalcarenow) or Google+ (+haney mallemat)



Title: Antibiotic Dosing for Burn Patients

Category: Critical Care

Posted: 11/13/2012 by Mike Winters, MBA, MD

Burn Patients and Antibiotic Dosing

  • Burn patients have a number of abnormalities in the early postinjury phase that can significantly impact the efficacy of antimicrobial therapy.  These include hypovolemia, hypoalbuminemia, and increasing GFR.
  • A few pearls when dosing select antibiotics in burn patients:
    • Aminoglycosides: in the absence of renal impairment, consider more frequent dosing to achieve adequate concentrations.
    • Beta-lactams: typical doses often don't reach effective concentrations; increase the dose, frequency of administration, or duration of infusion.
    • Vancomycin: the typical dose of 1 gm is usually ineffective; use a larger loading dose (15-20 mg/kg).
    • Linezolid: standard doses are usually ineffective; use a higher initial dose.

Show References

Jamal JA, et al. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Curr Opin Crit Care 2012; 18:460-71.



Title: Too much salt may NOT be sweet.

Category: Critical Care

Posted: 11/6/2012 by Haney Mallemat, MD

Previous pearls have described the increasing evidence against colloid (e.g., hydroxyethyl starch) use during resuscitation. Now it appears that the crystalloid 0.9% normal saline (NS) may be under fire. 

The use of large volumes of NS has been associated with hyperchloremic metabolic acidosis and harm in animal studies. The risk of harm in humans, however, has been less clear. 

Bellomo et al. conducted a prospective observational study in which patients being resuscitated in the control group received NS at the clinicians' discretion; i.e., chloride-liberal strategy. The use of NS was restricted in the intervention group, where other less chloride containing fluids were used for resuscitation (e.g., Ringer's Lactate); i.e., a chloride-restrictive strategy. 

The authors found that when compared to patients in the chloride-liberal group, the chloride-restrictive group had significantly less rise in baseline creatinine, less overall AKI, and a reduced need for renal replacement therapy.

Bottom line: Although this was only an observational study, the liberal use of normal saline during resuscitation may increase the risk of AKI and renal replacement therapy. 

Show References

Bellomo, R. et al. Association between a chloride-liberal vs. chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012 Oct 17;308(15):1566-72. doi: 10.1001/jama.2012.13356.

Follow me on Twitter (@criticalcarenow) and Google+ (+haney mallemat)

 



Title: Serotonin Toxicity

Category: Critical Care

Posted: 10/30/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

Serotonin Toxicity in the Critically Ill

  • Serotonin toxicity (aka serotonin syndrome) can easily be overlooked and misdiagnosed in many of our critically ill patients.
  • Several common ED medications are associated with serotonin toxicity and include tramadol, linezolid, ondansetron, and metoclopramide.
  • Clues to the diagnosis include hyperthermia, increased muscle tone, hyperreflexia, dilated pupils and clonus.  Of these, clonus is the most sensitive and specific sign.
  • A few important treatment pearls:
    • Avoid physical restraints
    • Consider cyproheptadine: only available in PO form; initial dose is 12 mg
    • Avoid dopamine for those that need vasopressors
    • Avoid bromocriptine and dantrolene

Show References

Bienvenu OJ, Neufeld KJ, Needham DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med 2012; 40:2662-2670.



Title: Sugar isn't always so sweet

Category: Critical Care

Posted: 10/24/2012 by Haney Mallemat, MD (Updated: 10/24/2012)

A study by Perner, et al recently published in NEJM observed that using hydroxyethyl starch (HES) as a resuscitation fluid increased mortality and renal replacement therapy at 90 days as compared to lactated acetate.
 
Another recent trial, called the “Crystalloid versus Hydroxyethyl Starch Trial” (CHEST) was a prospective randomized control trial from Australia comparing the use of 6% HES and 0.9% sodium chloride as a resuscitation fluid in the critically ill. 
 
With 7,000 patients enrolled (3,500 in each group), the CHEST trial is the largest single-trial of HES to date; the primary outcome was 90-day mortality and secondary outcomes were acute kidney injury (AKI) and renal-replacement therapy
 
The study concluded that there was no difference between groups for either morality or renal failure, but significantly more patients in the HES group required renal replacement therapy.
 
Bottom line: There is still no convincing data that patients receiving HES as part of their resuscitation have better outcomes compared to crystalloid (normal saline or lactated ringers) and there is increased harm with their use. Furthermore, the increased cost of HES does not appear to justify their routine use.

Show References

Perner A., et al. Hydroxyethyl Starch 130/0.4 versus Ringer's Acetate in Severe Sepsis. NEJM. 2012 Jun 27.

 
MyBurgh, J. Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care. N Engl J Med. 2012 Oct 17.
 
Follow me on twitter (@criticalcarenow) or Google+ (+haney mallemat) 


Title: Delirium in the Critically Ill

Category: Critical Care

Posted: 10/16/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

Delirium in the Critically Ill

  • Delirium has been shown to be an independent predictor of mortality and can occur in up to 75% of critically ill patients.
  • Whether preventing or treating delirium in the critically ill patient, consider the following:
    • Minimize the use of anticholinergic medications (i.e. diphenhydramine, chlorpromazine)
    • Ensure pain is adequately controlled (avoid meperidine and tramadol)
    • Be careful with sedative medications; consider bolus dosing and daily interruption of continuous infusions
  • Additional measures to treat delirious patients include reducing sensory deprivation, promoting normal sleep-wake cycles, early physical rehabilitation, and treating psychosis.

Show References

Bienvenu OJ, Neufeld KJ, Needham DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med 2012; 40:2662-2670.



Title: What's the Diagnosis? Critical Care Edition

Category: Critical Care

Posted: 10/9/2012 by Haney Mallemat, MD

Question

70 year-old male recently treated for community-acquired pneumonia presents with bloody diarrhea, fever, and severe abdominal pain. Abdominal Xray is shown below. Diagnosis?  

Show Answer

Answer: Toxic Megacolon

Toxic megacolon (TM) is an acute colitis with segmental or total colonic dilation (>6cm) plus systemic toxicity.

Actual incidence is unknown, but it is believed that TM is rising because of increasing cases of Clostridium difficile and the aging population. 

The most common etiologies are ulcerative, chron, and pseudomembranous colitis, but other causes exist and can be categorized as:

  • Inflammatory (e.g., ulcerative colitis, Behcet's disease, etc.)
  • Infectious (e.g., Clostridium difficile, Salmonella, Shigella, CMV, etc.)
  • Ischemia  
  • Miscellaneous (chemotherapy, Kaposi sarcoma, etc.)

The diagnosis is made based on clinical evidence of colitis plus evidence of colonic dilation on abdominal XR (diameter > 6cm, loss of haustra, or free intraperitoneal air secondary to perforation) or CT scan (demonstrating dilation or perforation).

Treatment includes:

  • Aggressive fluid resuscitation and vasopressors/inotropes.
  • Broad-spectrum antibiotics
  • NPO, NG tube for bowel decompression, and avoiding medications reducing GI motility (e.g., narcotics)
  • Early surgical evaluation is required although definitive surgical care (including colectomy) may be delayed for up to 3 days while monitoring the response to conservative treatment.

Show References

Autenrieth, D et al. Toxic Megacolon Inflammatory Bowel Dis. 2011 Aug 29. 

Follow me on Twitter (@criticalcarenow) or Google+ (+haney mallemat)



Title: TTP

Category: Critical Care

Posted: 10/2/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

Thrombotic Thrombocytopenic Purpura (TTP)

  • TTP is a true hematologic emergency.  As a result of delays in diagnosis and initiation of treatment, mortality remains around 20%.
  • Often, patients present with nonspecific symptoms that include weakness, anorexia, nausea, vomiting, and diarrhea.
  • Recall that the textbook pentad is rarely present upon presentation.  In fact, renal failure and neurologic deficits are late findings.
  • Plasma exchange remains the treatment of choice for critically ill ED patients with TTP.
  • If plasma exchange is not immediately available, consider FFP (15-30 ml/kg) and methylprednisolone (10 mg/kg).

Show References

Kessler CS, et al. Thrombotic thrombocytopenic purpura: A hematological emergency. J Emerg Med 2012; 43:538-44.



Title: Does a cuff-leak mean anything?

Category: Critical Care

Posted: 9/25/2012 by Haney Mallemat, MD

Intubated patients may occasionally meet certain criteria for extubation while in the Emergency Department. Extubation is not without its risk, however, as up to 30% of patients have respiratory distress secondary to laryngeal and upper airway edema, with some patients requiring re-intubation.

Prior to extubation, Intensivists use a brief “cuff-leak” test (deflation of the endotracheal balloon to assess the presence or absence of an air-leak around the tube) to indirectly screen for the presence of upper airway edema and ultimately the risk of re-intubation. The cuff-leak test is performed by deflating the endotracheal balloon followed by one or more of the following maneuvers:

  • Using the ventilator to measure the difference between inspired and expired tidal volumes; if there is a difference in the measured volumes, then air is “leaking” around the endotracheal tube, implying minimal airway edema.
  • Auscultation for an air “leak” around the tube during mechanical ventilation; auscultation of a leak implies that air is passing around the tube and minimal airway edema is present.
  • Disconnecting the patient from the ventilator and occluding the endotracheal tube during spontaneous breathing; auscultation of a leak implies that there is air passing around the tube and minimal airway edema is present.

Ochoa et al. performed a systematic review to determine the accuracy of the “cuff-leak” test to predict upper airway edema prior to extubation. The authors concluded that a positive cuff-leak test (i.e., absence of an air-leak) indicates an elevated risk of upper airway obstruction and re-intubation. A negative cuff-leak test (i.e., presence of an air-leak), however, does not reliably exclude the presence of upper airway edema or the need for subsequent re-intubation.

Bottom line: No test prior to extubation reliably predicts the absence of upper airway edema. Patients extubated in the Emergency Department require close observation with airway equipment located nearby.

 

Show References

Ochoa, ME et al. Cuff-leak test for the diagnosis of upper airway obstruction in adults: A systematic review
and meta-analysis. Intensive Care Med (2009) 35:1171–1179

Follow me on Twitter @criticalcarenow or Google+ (+Haney Mallemat)



Title: Lung Transplant Pt.

Category: Critical Care

Posted: 9/18/2012 by Mike Winters, MBA, MD

The Lung Transplant Patient in Your ED

  • The number of lung transplant recipients is increasing.  With improved immunosuppressant medications, pts are living longer.  In fact, the 5-yr survival rate is now approximately 60%.
  • When evaluating a lung transplant pt who is < 1 yr following transplant, think about acute rejection and infection
  • Acute rejection occurs in up to 40% of pts, can present with cough, SOB, malaise, or hypoxia, and is treated with high-dose corticosteroids.
  • Infection
    • Bacterial infections usually occur in the early stages following transplant, with Pseudomonas the predominant organism
    • CMV is the most common organism affecting up to 33% of pts during the first year after transplant

Show References

Fuehner T, et al. The lung transplant patient in the ICU. Curr Opin Crit Care 2012; 18:472-8.



Title: Non-Cardiogenic Pulmonary Edema

Category: Critical Care

Posted: 9/11/2012 by Haney Mallemat, MD

Question

40 year-old male with severe uncontrolled hypertension presents with altered mental status (head CT below). The CXR is from the same patient. What's the connection?

Show Answer

Answer: Neurogenic pulmonary edema (NPE)

NPE is defined as acute pulmonary edema following central nervous system (CNS) insult; NPE has been recognized for over 100 years, but its incidence is underreported due to a lack objective clinical criteria. 

The pathophysiology of NPE is poorly understood but it is generally believed that both cardiogenic and non-cardiogenic pulmonary edema play a role. CXR (see above) demonstrates a pattern similar to acute respiratory distress syndrome (i.e., bilateral interstitial infiltrates). 

CNS insults that are abrupt, rapidly progressive, and increase intracranial pressure (e.g., subarachnoid hemorrhage, intraparenchymal hemorrhage, traumatic brain injury, subdural, etc.) have the highest risk for NPE. Neural injury leads to sympathetic activation, the release of catecholamines, and one or all of the following:

  • Direct myocardial injury and cardiac dysfunction
  • Increased systemic afterload causing left ventricular dysfunction
  • Increased pulmonary vascular permeability and leak 

Treatment of NPE includes:

  • Reversing and treating the underlying disorder
  • Supplemental oxygen with positive pressure ventilation as necessary
  • Low-tidal volume  ventilation (if mechanically ventilated) with appropriate PEEP
  • Cautious use of diuretics, as adequate intravascular volume is needed for cerebral perfusion
  • Specific pharmacologic measures (eg. alpha blockers) have been studied but their efficacy is unclear and are not recommended as symptoms typically resolve within 72 hours

Show References

Davidson, D. et al. Neurogenic pulmonary edema. Crit Care. 2012 Mar 20;16(2):212.

Follow me on Twitter (@criticalcarenow) and Google+ (+haneymallemat)



Title: Right Heart Failure in the Critically Ill

Category: Critical Care

Posted: 9/4/2012 by Mike Winters, MBA, MD (Updated: 9/4/2026)

Right Heart Failure in the Critically Ill

  • In its most simplistic form, right heart failure (RHF) is due to either to right ventricular contractile dysfunction or elevated right ventricular afterload.
    • Primary causes of RV contractile dysfunction include: coronary ischemia, sepsis, drug toxicity, and acute pulmonary hypertension
    • Primary causes of increased RV afterload include: LV dysfunction, venous thromboembolism, hypoxic pulmonary vasoconstriction, and lung injury
  • Management of the patient with RHF centers on identifying and treating reversible causes, optimizing preload, inotropes, and possible implantation of a right ventricular assist device.
  • Importantly, excessive volume loading can worsen RV contractile function, increase RV dilatation, and impair LV output and systemic perfusion.
  • Consider early use of inotropic agents, such as dobutamine, in critically ill patients with RHF.

Show References

Greyson CR. Right heart failure in the intensive care unit. Curr Opin Crit Care 2012; 18:424-31.



Title: What's the paralytic of choice during rapid sequence intubation?

Category: Critical Care

Posted: 8/28/2012 by Haney Mallemat, MD

A Cochrane review of 37 studies concluded that Succinylcholine (SUC) is superior to Rocuronium (ROC) during rapid sequence intubation.

The authors claim that compared to ROC, SUC has a faster onset of action (45 vs. 60 seconds) and overall a shorter duration of action (10 vs. 60 minutes).

Dr. Reuben Strayer wrote a letter to the journal editors and stated that these findings should be interpreted carefully; he highlighted that most of the studies in the review used doses of ROC less than 0.9 mg/kg (most studies used 0.6mg/kg).

Dr. Strayer asserted that ROC’s onset of action is dose dependent; when using doses of 1.2 mg/kg, ROC’s onset is indistinguishable from that of SUC. He also stated another major benefit of ROC is the lack of adverse effects that SUC possesses (hyperkalemia and malignant hyperthermia).

What are your thoughts on this? Go to http://www.facebook.com/Criticalcarenow and take the poll (there are 5 choices). Results will be posted next week.

Show References

Seupaul RA, Jones JH. Evidence-based emergency medicine. Does succinylcholine maximize intubating conditions better than rocuronium for rapid sequence intubation? Ann Emerg Med. 2011 Mar;57(3):301-2. Epub 2010 Nov 18.

Strayer RJ. Rocuronium versus succinylcholine: Cochrane synopsis reconsidered. Ann Emerg Med. 2011 Aug;58(2):217-8.

Follow me on Twitter (@criticalcarenow) and Google+ (+haney mallemat)

 



Previous  |  1 |  ... |  26 |  27 |  28 |  29 |  30 |  31 |  32 |  33 |  34 |  35 |  36 |  ... |  45 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map